These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8521394)

  • 1. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines.
    Boyer JC; Umar A; Risinger JI; Lipford JR; Kane M; Yin S; Barrett JC; Kolodner RD; Kunkel TA
    Cancer Res; 1995 Dec; 55(24):6063-70. PubMed ID: 8521394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
    Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
    Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
    Yeh CC; Lee C; Dahiya R
    Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair and microsatellite instability in esophageal cancer cells.
    Uchida N; Kumimoto H; Nishizawa K; Tokumasu S; Harada H; Shimada Y; Ishizaki K
    Int J Cancer; 2001 Mar; 91(5):687-91. PubMed ID: 11267981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects of DNA mismatch repair in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
    Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
    Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
    Marcus VA; Madlensky L; Gryfe R; Kim H; So K; Millar A; Temple LK; Hsieh E; Hiruki T; Narod S; Bapat BV; Gallinger S; Redston M
    Am J Surg Pathol; 1999 Oct; 23(10):1248-55. PubMed ID: 10524526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1.
    Shin KH; Park JG
    Eur J Cancer; 2000 May; 36(7):925-31. PubMed ID: 10785599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity.
    Risinger JI; Umar A; Boyer JC; Evans AC; Berchuck A; Kunkel TA; Barrett JC
    Cancer Res; 1995 Dec; 55(23):5664-9. PubMed ID: 7585651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
    Johannsdottir JT; Bergthorsson JT; Gretarsdottir S; Kristjansson AK; Ragnarsson G; Jonasson JG; Egilsson V; Ingvarsson S
    Anticancer Res; 1999; 19(3A):1821-6. PubMed ID: 10470121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells.
    Leung WK; Kim JJ; Wu L; Sepulveda JL; Sepulveda AR
    J Biol Chem; 2000 May; 275(21):15728-32. PubMed ID: 10748105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability in human solid tumors.
    Lothe RA
    Mol Med Today; 1997 Feb; 3(2):61-8. PubMed ID: 9060003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability.
    Ma AH; Xia L; Littman SJ; Swinler S; Lader G; Polinkovsky A; Olechnowicz J; Kasturi L; Lutterbaugh J; Modrich P; Veigl ML; Markowitz SD; Sedwick WD
    Oncogene; 2000 Apr; 19(18):2249-56. PubMed ID: 10822375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.
    Wei Q; Bondy ML; Mao L; Gaun Y; Cheng L; Cunningham J; Fan Y; Bruner JM; Yung WK; Levin VA; Kyritsis AP
    Cancer Res; 1997 May; 57(9):1673-7. PubMed ID: 9135006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for involvement of yeast proliferating cell nuclear antigen in DNA mismatch repair.
    Johnson RE; Kovvali GK; Guzder SN; Amin NS; Holm C; Habraken Y; Sung P; Prakash L; Prakash S
    J Biol Chem; 1996 Nov; 271(45):27987-90. PubMed ID: 8910404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors.
    Senba S; Konishi F; Okamoto T; Kashiwagi H; Kanazawa K; Miyaki M; Konishi M; Tsukamoto T
    Cancer; 1998 Jan; 82(2):279-85. PubMed ID: 9445183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch repair deficiency in hematological malignancies with microsatellite instability.
    Gu L; Cline-Brown B; Zhang F; Qiu L; Li GM
    Oncogene; 2002 Aug; 21(37):5758-64. PubMed ID: 12173046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.
    Xicola RM; Llor X; Pons E; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Duque JM; Nicolás-Pérez D; Garcia AM; Rigau J; Gassull MA;
    J Natl Cancer Inst; 2007 Feb; 99(3):244-52. PubMed ID: 17284719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
    Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.